Time Course of Oxidative Stress Status in the Postprandial and Postabsorptive States in Type 1 Diabetes Mellitus: Relationship to Glucose and Lipid Changes

Journal of the American College of Nutrition

Volumn 24, Issue 6, 2005, Pages 474-485

  Manuel y Keenoy, Begoña ^a   Van Campenhout, Ann ^a   Aerts, Petra ^a   Vertommen, Jan ^a   Abrams, Pascale ^b   Van Gaal, Luc F ^b   Van Gils, Carolien ^b   De Leeuw, Ivo H ^b  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Antioxidants; Lipid peroxidation; Oxidative stress; Postabsorptive; Postprandial; Type 1 diabetes mellitus

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; GLUCOSE; GLUTATHIONE; INSULIN; LIPID; MALONALDEHYDE; RETINOL; THIOL DERIVATIVE; TRIACYLGLYCEROL; URIC ACID;

ABSORPTION; ADULT; ARTICLE; CLINICAL ARTICLE; DIET RESTRICTION; FAT INTAKE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPID BLOOD LEVEL; LIPID PEROXIDATION; MALE; MEAL; OXIDATIVE STRESS; POSTPRANDIAL STATE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; AREA UNDER THE CURVE; BLOOD; FOOD; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

ABSORPTION; ADULT; ANTIOXIDANTS; AREA UNDER CURVE; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; FASTING; FEMALE; FOOD; GLUTATHIONE; HUMANS; INSULIN; LIPID PEROXIDATION; LIPIDS; MALE; MIDDLE AGED; OXIDATIVE STRESS; POSTPRANDIAL PERIOD; TRIGLYCERIDES;

EID: 33644843936     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2005.10719493     Document Type: Article

References (77)

1. Syvanne M, Taskinen MR: Lipids and lipoproteins as coronary risk factors in non-insulin-dependent diabetes mellitus. Lancet 350: SI20-SI23, 1997.
2. Koya D, King L: Protein kinase C activation and the development of diabetic complications. Diabetes 47: 859-866, 1998.
3. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404: 787-790, 2000.
4. Brownlee M: Glycation and diabetic complications. Diabetes 43: 836-841, 1994.
5. Wolff SP: Diabetes mellitus and free radicals. Free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications. Br Med Bull 49: 642-652, 1993.
6. Tsai EC, Hirsch IB, Brunzell JD, Chait A: Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM. Diabetes 43: 1010-1014, 1994.
7. Rabini RA, Fumelli P, Galassi R, Dousset N, Taus M, Ferretti G, Mazzanti L, Curatola G, Solera ML, Valdiguie P: Increased susceptibility to lipid oxidation of low-density lipoproteins and erythrocyte membranes from diabetic patients. Metabolism 43: 1470-1474, 1994.
8. Griesmacher A, Kindhauser M, Andert SE, Schreiner W, Toma C, Knoebl P, Pietschmann P, Prager R, Schnack C, Schernthaner G: Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus. Am J Med 98: 469-475, 1995.
9. Baynes JW: Role of oxidative stress in development of complications in diabetes. Diabetes 40: 405-412, 1991.
10. Dandona P, Thusu K, Cook S, Snyder B, Makowski J, Armstrong D, Nicotera T: Oxidative damage to DNA in diabetes mellitus. Lancet 347: 444-445, 1996.
11. Temelkova-Kurktschiev TS, Koehler C, Henkel E, Leonhardt W, Fuecker K, Hanefeld M: Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbAlc level. Diabetes Care 23: 1830-1834, 2000.
12. Teno S, Uto Y, Nagashima H, Endoh Y, Iwamoto Y, Omori Y, Takizawa T: Association of postprandial hypertriglyceridemia and carotid intima-media thickness in patients with type 2 diabetes. Diabetes Care 23: 1401-1406, 2000.
13. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H: Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study. Br Med J (Clin Res Ed) 287: 867-870, 1983.
14. Abbott RD, Donahue RP, MacMahon SW, Reed DM, Yano K: Diabetes and the risk of stroke. The Honolulu Heart Program. JAMA 257: 949-952, 1987.
15. Hanefeld M, Fischer S, Julius U, Schulze J, Schwanebeck U, Schmechel H, Ziegelasch HJ, Lindner J: Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia 39: 1577-1583, 1996.
16. Bonora E, Muggeo M: Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence. Diabetologia 44: 2107-2114, 2001.
17. Ceriello A: Acute hyperglycaemia and oxidative stress generation. Diabet Med 14 3: S45-S49, 1997.
18. Ceriello A: The post-prandial state and cardiovascular disease: relevance to diabetes mellitus. Diabetes Metab Res Rev 16: 125-132, 2000.
19. Duthie GG, Morrice PC, Ventresca PG, McLay JS: Effects of storage, iron and time of day on indices of lipid peroxidation in plasma from healthy volunteers. Clin Chim Acta 206: 207-213, 1992.
20. Ceriello A, Bortolotti N, Motz E, Crescentini A, Lizzio S, Russo A, Tonutti L, Taboga C: Meal-generated oxidative stress in type 2 diabetic patients. Diabetes Care 21: 1529-1533, 1998.
21. Ceriello A, Quagliaro L, Catone B, Pascon R, Piazzola M, Bais B, Marra G, Tonutti L, Taboga C, Motz E: Role of hyperglycemia in nitrotyrosine postprandial generation. Diabetes Care 25: 1439-1443, 2002.
22. Sampson MJ, Gopaul N, Davies IR, Hughes DA, Carrier MJ: Plasma F2 isoprostanes: direct evidence of increased free radical damage during acute hyperglycemia in type 2 diabetes. Diabetes Care 25: 537-541, 2002.
23. Beisswenger PJ, Howell SK, O'Dell RM, Wood ME, Touchette AD, Szwergold BS: (alpha)-dicarbonyls increase in the postprandial period and reflect the degree of hyperglycemia. Diabetes Care 24: 726-732, 2001.
24. Wittenstein B, Klein M, Finckh B, Ullrich K, Kohlschutter A: Plasma antioxidants in pediatric patients with glycogen storage disease, diabetes mellitus, and hypercholesterolemia. Free Radic Biol Med 33: 103-110, 2002.
25. Dominguez C, Ruiz E, Gussinye M, Carrascosa A: Oxidative stress at onset and in early stages of type 1 diabetes in children and adolescents. Diabetes Care 21: 1736-1742, 1998.
26. Manuel-y-Keenoy B, Vertommen J, Abrams P, Van Gaal L, De Leeuw I, Messeri D, Poscia A: Postprandial glucose monitoring in type 1 diabetes mellitus: use of a continuous subcutaneous monitoring device. Diabetes Metab Res Rev 20: S24-S31, 2004.
27. Friedewald WT, Levy M, Frederickson DS: Estimation of the concentration of low density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge. Clin Chem 18: 499-502, 1972.
28. Caye-Vaugien C, Krempf M, Lamarche P, Charbonnel B, Pieri J: Determination of a-tocopherol in plasma, platelets and erythrocytes of type I and type II diabetic patients by HPLC. Int J Vitam Nutr Res 60: 324-330, 1990.
29. Washko PW, Hartzell WO, Levine M: Ascorbic acid analysis using high-performance liquid chromatography with coulometric electrochemical detection. Anal Biochem 181: 276-282, 1989.
30. Beutler E: Reduced glutathione (GSH). In Beutler E, Orland FL (eds): "Red Cell Metabolism: A Manual of Biochemical Methods," 2nd ed. New York: Grune & Stratton Inc, pp 131-132, 1975.
31. Hall ND, Blake DR, Bacon PA: Serum sulphydryl levels in early synovitis. J Rheumatol 9: 593-596, 1982.
32. Lissi E, Salim-Hanna M, Pascual C, del Castillo MD: Evaluation of total antioxidant potential (TRAP) and total antioxidant reactivity from luminol-enhanced chemiluminescence measurements. Free Radic Biol Med 18: 153-158, 1995.
33. Nielsen F, Mikkelsen BB, Nielsen JB, Andersen HR, Grandjean P: Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors. Clin Chem 43: 1209-1214, 1997.
34. BECEL: BECEL Voedingsprogramma versie 5.0. Van den Berg, 1995, Hartog-Union.
35. NUBEL. Belgische voedingsmiddelentabel, Brussel. 1995, Brussel.
36. NEVO. Nevotabel 1996: herwerkte versie 1998.
37. Van der Heyden LJM, Hulshof KFAM, Languis JAE, Van Oosten HM, Pruissen-Boskaljon JC, Van Stratum P. Zeist, The Netherlands: Krips Repro Meppel, 1998.
38. Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF: Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 19: 644-655, 1970.
39. Raben A, Holst JJ, Madsen J, Astrup A: Diurnal metabolic profiles after 14 d of an ad libitum high-starch, high-sucrose, or high-fat diet in normal-weight never-obese and postobese women. Am J Clin Nutr 73: 177-189, 2001.
40. Anderson RA, Evans ML, Ellis GR, Graham J, Morris K, Jackson SK, Lewis MJ, Rees A, Frenneaux MP: The relationships between post-prandial lipaemia, endothelial function and oxidative stress in healthy individuals and patients with type 2 diabetes. Atherosclerosis 154: 475-483, 2001.
41. Idris I, Gray S, Donnelly R. Protein kinase C activation: isozymespecific effects on metabolism and cardiovascular complications in diabetes. Diabetologia 44, 659-673, 2001.
42. Koya D, Jirousek M, Lin Y-W, King GL: Characterization of protein kinase C beta-isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J Clin Invest 100: 115-126, 1997.
43. Mohanty P, Ghanim H, Hamouda W, Aljada A, Garg R, Dandona P: Both lipid and protein intakes stimulate increased generation of reactive oxygen species by polymorphonuclear leukocytes and mononuclear cells. Am J Clin Nutr 75: 767-772, 2002.
44. Wolff S, Dean R: Glucose autoxidation and protein modification. Biochem J 245: 243-250, 1987.
45. Hunt J, Smith C, Wolff S: Autoxidative glycosylation and possible involvement of peroxides and free radicals in LSL modification by glucose. Diabetes 39: 1420-1424, 1990.
46. Mullarkey C, Edelstein D, Brownlee M: Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochem Biophys Res Comm 173: 932-939, 1990.
47. Travis SF, Morrison AD, Clements RS, Winegrad AI, Oski FA: Metabolic alterations in the human erythrocyte produced by increases in glucose concentration. The role of the polyol pathway. J Clin Invest 50: 2104-2112, 1971.
48. Williamson J, Chang K., Frangos M, Hasan K, Tilton R: Hyperglycemic Pseudohypoxia and diabetic complications. Diabetes 42: 801-813, 1993.
49. Kashiwagi A, Ikebuchi M, Shigeta Y: Abnormal glutathion metabolism and increased cytotoxicity caused by H2O2 in human umbilical vein endothelial cells cultured in high glucose medium. Diabetologia 37: 264-269, 1994.
50. Packer L: The role of anti-oxidative treatment in diabetes mellitus. Diabetologia 36: 1212-1213, 1993.
51. Sinclair AJ, Girling AJ, Gray L, Le Guen C, Lunec J: Disturbed handling of ascorbic acid in diabetic patients with and without microangiopathy during high dose ascorbate supplementation. Diabetologia 34: 171-175, 1991.
52. Ceriello A, Bortolotti N, Crescentini A, Motz E, Lizzio S, Russo A, Ezsol Z, Tonutti L, Taboga C: Antioxidant defences are reduced during the oral glucose tolerance test in normal and non-insulindependent diabetic subjects. Eur J Clin Invest 28: 329-333, 1998.
53. Tessier D, Khalil A, Fulop T: Effects of an oral glucose challenge on free radicals/antioxidants balance in an older population with type II diabetes. J Gerontol A Biol Sci Med Sci 54: M541-M545, 1999.
54. Wessner B, Strasser E-M, Spittler A, Roth E: Effect of single and combined supply of glutamine, glycine, N-acetylcysteine, and R, S-[alpha]-lipoic acid on glutathione content of myelomonocytic cells. Clin Nutr 22: 515-522, 2003.
55. Manuel-y-Keenoy B, Vertommen J, De Leeuw I: Divergent effects of different oxidants on glutathione homeostasis and protein damage in erythrocytes from diabetic patients: effects of high glucose. Mol Cell Biochem 225: 59-73, 2001.
56. Dierckx N, Horvath G, van Gils C, Vertommen J, van de Vliet J, De Leeuw I, Manuel-y-Keenoy B: Oxidative stress status in patients with diabetes mellitus: relationship to diet. Eur J Clin Nutr 57: 999-1008, 2003.
57. Thornalley P, McLellan A, Sönksen P: Negative association between erythrocyte reduced glutathione concentration and diabetic complications. Clin Sci 91: 575-582, 1996.
58. Murakami K, Kondo T, Kawakami Y: Impairment of glutathione metabolism in erythrocytes from patients with diabetes mellitus. Metabolism 38: 753-758, 1989.
59. Blakytny R, Harding JJ: Glycation (non-enzymic glycosylation) inactivates glutathione reductase. Biochem J 288: 303-307, 1992.
60. Title LM, Cummings PM, Giddens K, Nassar BA: Oral glucose loading acutely attenuates endothelium-dependent vasodilation in healthy adults without diabetes: an effect prevented by vitamins C and E. J Am Coll Cardiol 36: 2185-2191, 2000.
61. Bode AM, Yavarow CR, Fry DA, Vargas T: Enzymatic basis for altered ascorbic acid and dehydroascorbic acid levels in diabetes. Biochem Biophys Res Commun 191: 1347-1353, 1993.
62. Galvan AQ, Muscelli E, Catalano C: Insulin decreases circulating vitamin E levels in humans. Metabolism 45: 998-1003, 1996.
63. Welch RW, Bergsten P, Butler JD, Levine M: Ascorbic acid accumulation and transport in human fibroblasts. Biochem J 294: 505-510, 1993.
64. Padh H, Subramoniam A, Aleo JJ: Glucose inhibits cellular ascorbic acid uptake by fibroblasts in vitro. Cell Biol Int Rep 9: 531-538, 1985.
65. Becker BF: Towards the physiological function of uric acid. Free Radic Biol Med 14: 615-631, 1993.
66. Desco MC, Asensi M, Marquez R, Martinez-Valls J, Vento M, Pallardo FV, Sastre J, Vina J: Xanthine oxidase is involved in free radical production in type 1 diabetes: protection by allopurinol. Diabetes 51: 1118-1124, 2002.
67. Lavie L: Obstructive sleep apnoea syndrome-an oxidative stress disorder. Sleep Med Rev 7: 35-51, 2003.
68. Yeum KJ, Aldini G, Chung HY, Krinsky NI, Russell RM: The activities of antioxidant nutrients in human plasma depend on the localization of attacking radical species. J Nutr 133: 2688-2691, 2003.
69. Halliwell B, Gutteridge JM: The definition of antioxidants in biological systems. Free Radic Biol Med 18: 125-126, 1995.
70. Frei B, Stocker R, Ames BN: Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci USA 85: 9748-9752, 1988.
71. Frei B, England L, Ames BN: Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci USA 86: 6377-6381, 1989.
72. Staprans I, Hardman DA, Pan XM, Feingold KR: Effect of oxidized lipids in the diet on oxidized lipid levels in postprandial serum chylomicrons of diabetic patients. Diabetes Care 22: 300-306, 1999.
73. Scheffer PG, Bakker SJ, Popp-Snijders C, Heine RJ, Schutgens RB, Teerlink T: Composition of LDL as determinant of its susceptibility to in vitro oxidation in patients with well-controlled type 2 diabetes. Diabetes Metab Res Rev 17: 459-466, 2001.
74. Heine RJ, Dekker JM: Beyond postprandial hyperglycaemia: metabolic factors associated with cardiovascular disease. Diabetologia 45: 461-475, 2002.
75. Krieger-Brauer HI, Kather H: Human fat cells possess a plasma membrane-bound H2O2-generating system that is activated by insulin via a mechanism bypassing the receptor kinase. J Clin Invest 89: 1006-1013, 1992.
76. Paolisso G, Giugliano D: Oxidative stress and insulin action: is there a relationship? Diabetologia 39: 357-363, 1996.
77. Schiekofer S, Andrassy M, Chen J, Rudofsky G, Schneider J, Wendt T, Stefan N, Humpert P, Fritsche A, Stumvoll M, Schleicher E, Haring HU, Nawroth PP, Bierhaus A: Acute hyperglycemia causes intracellular formation of CML and activation of ras, p42/44 MAPK, and nuclear factor (kappa)B in PBMCs. Diabetes 52: 621-633, 2003.